Osteosarcoma cells highly express the cluster of differentiation 44 (CD44), which is a receptor for hyaluronic acid (HA), and the HA-binding participates in various tumor activities, including tumor progression, metastasis, and drug resistance (Xiao et al., 2018). This evidence concerns the gene CD44 and neoplasm.